CytoSorbents CTSO 深 沪
等待开盘 11-18 09:30:00 美东时间
0.6562
-0.004
-0.58%
华盛通- 最 高0.70
- 今 开0.66
- 成交量 8.15万股
- 最 低 0.6562
- 昨 收 0.66
- 总市值 4108.49万
- 52周最高 1.61
- 市盈率 静 --
- 换手率 0.13%
- 52周最低 0.60
- 委 比 36.48%
- 总股本 6261.04万
- 历史最高 15.24
- 量 比 0.46
- 振 幅 6.64%
- 历史最低 0.60
- 每 手 1
- 风险率 0.12%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 花旗上调Bilibili目标价升至27美元； 摩根士丹利上调英伟达目标价升至220美元；Ardent Health、Stubhub遭多家大行下调评级
花旗上调Bilibili目标价升至27美元； 摩根士丹利上调英伟达目标价升至220美元；Ardent Health、Stubhub遭多家大行下调评级>>
11-17 10:49
HC Wainwright & Co. Maintains Neutral on CytoSorbents, Lowers Price Target to $0.75
HC Wainwright & Co. analyst Sean Lee maintains CytoSorbents (NASDAQ:CTSO) with a Neutral and lowers the price target from $1 to $0.75.
11-14 21:07
CytoSorbents Q3 Adj. EPS $(0.04) Beats $(0.05) Estimate, Sales $9.485M Miss $10.034M Estimate
CytoSorbents (NASDAQ:CTSO) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.05) by 14.89 percent. This is a 50 percent increase over losses of $(0.08) per share from the
11-14 05:09
Earnings Scheduled For November 13, 2025
Companies Reporting Before The Bell • Edgewell Personal Care (NYSE:EPC) is proj...
11-13 19:11
美股大行评级 | Arete Research上调百度"买入"评级，目标价143美元；瑞银上调蔚来"买入"评级，目标价升至8.5美元
今日重点评级关注：HC Wainwright & Co.：维持Orion Energy Sys"买入"评级，目标价从2美元升至20美元；高盛：维持Amylyx Pharmaceuticals"买入"评级，目标价从10美元升至20美元
09-17 10:15
D. Boral Capital Maintains Buy on CytoSorbents, Maintains $10 Price Target
D. Boral Capital analyst Jason Kolbert maintains CytoSorbents (NASDAQ:CTSO) with a Buy and maintains $10 price target.
09-16 21:11
CytoSorbents To Refile De Novo Application For DrugSorb-ATR, Expects FDA Review In Mid-2026
CytoSorbents Corporation (NASDAQ:CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today provided a regulatory update on
09-16 19:14
CytoSorbents Provides DrugSorb-ATR Regulatory Update
PRINCETON, N.J., Sept. 16, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surge...
09-16 19:00
CytoSorbents to Present at the H.C. Wainwright 27th Annual Global Investment Conference
PRINCETON, N.J., Sept. 5, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surger...
09-05 19:00
Why Rocket Pharmaceuticals Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket
Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) rose sharply in pre-market...
08-20 19:24
